aluates Reports

$ 0.0

Automative

Global Lanreotide Injection Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-0Q13270

Global Lanreotide Injection Market Research Report 2023

BUY CHAPTERS

Global Lanreotide Injection Market Research Report 2025

Code: QYRE-Auto-0Q13270

Report

May 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ipsen S A

Cipla Ltd

Lanreotide Injection Market Size

The global market for Lanreotide Injection was valued at US$ 504 million in the year 2024 and is projected to reach a revised size of US$ 665 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Lanreotide Injection Market

Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH. Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.

North American market for Lanreotide Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lanreotide Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Lanreotide Injection include Ipsen, Cipla, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lanreotide Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lanreotide Injection.

The Lanreotide Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lanreotide Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lanreotide Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lanreotide Injection Market Report

Report Metric	Details
Report Name	Lanreotide Injection Market
Accounted market size in year	US$ 504 million
Forecasted market size in 2031	US$ 665 million
CAGR	4.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Sustained Release Formulation Long-acting Formula
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ipsen, Cipla
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lanreotide Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lanreotide Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Lanreotide Injection Market growing?

Ans: The Lanreotide Injection Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Lanreotide Injection Market size in 2031?

Ans: The Lanreotide Injection Market size in 2031 will be US$ 665 million.

Who are the main players in the Lanreotide Injection Market report?

Ans: The main players in the Lanreotide Injection Market are Ipsen, Cipla

What are the Application segmentation covered in the Lanreotide Injection Market report?

Ans: The Applications covered in the Lanreotide Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Lanreotide Injection Market report?

Ans: The Types covered in the Lanreotide Injection Market report are Sustained Release Formulation, Long-acting Formula

Recommended Reports

Endocrine Disorders

Hormone Therapies

Adjunct Injection Drugs

1 Lanreotide Injection Market Overview

1.1 Product Definition

1.2 Lanreotide Injection by Type

1.2.1 Global Lanreotide Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 Sustained Release Formulation

1.2.3 Long-acting Formula

1.3 Lanreotide Injection by Application

1.3.1 Global Lanreotide Injection Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Lanreotide Injection Market Size Estimates and Forecasts

1.4.1 Global Lanreotide Injection Revenue 2020-2031

1.4.2 Global Lanreotide Injection Sales 2020-2031

1.4.3 Global Lanreotide Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Lanreotide Injection Market Competition by Manufacturers

2.1 Global Lanreotide Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Lanreotide Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Lanreotide Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Lanreotide Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Lanreotide Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Lanreotide Injection, Product Type & Application

2.7 Global Key Manufacturers of Lanreotide Injection, Date of Enter into This Industry

2.8 Global Lanreotide Injection Market Competitive Situation and Trends

2.8.1 Global Lanreotide Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Lanreotide Injection Players Market Share by Revenue

2.8.3 Global Lanreotide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Lanreotide Injection Market Scenario by Region

3.1 Global Lanreotide Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Lanreotide Injection Sales by Region: 2020-2031

3.2.1 Global Lanreotide Injection Sales by Region: 2020-2025

3.2.2 Global Lanreotide Injection Sales by Region: 2026-2031

3.3 Global Lanreotide Injection Revenue by Region: 2020-2031

3.3.1 Global Lanreotide Injection Revenue by Region: 2020-2025

3.3.2 Global Lanreotide Injection Revenue by Region: 2026-2031

3.4 North America Lanreotide Injection Market Facts & Figures by Country

3.4.1 North America Lanreotide Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Lanreotide Injection Sales by Country (2020-2031)

3.4.3 North America Lanreotide Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Lanreotide Injection Market Facts & Figures by Country

3.5.1 Europe Lanreotide Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Lanreotide Injection Sales by Country (2020-2031)

3.5.3 Europe Lanreotide Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Lanreotide Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Lanreotide Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Lanreotide Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Lanreotide Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Lanreotide Injection Market Facts & Figures by Country

3.7.1 Latin America Lanreotide Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Lanreotide Injection Sales by Country (2020-2031)

3.7.3 Latin America Lanreotide Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Lanreotide Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Lanreotide Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Lanreotide Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Lanreotide Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Lanreotide Injection Sales by Type (2020-2031)

4.1.1 Global Lanreotide Injection Sales by Type (2020-2025)

4.1.2 Global Lanreotide Injection Sales by Type (2026-2031)

4.1.3 Global Lanreotide Injection Sales Market Share by Type (2020-2031)

4.2 Global Lanreotide Injection Revenue by Type (2020-2031)

4.2.1 Global Lanreotide Injection Revenue by Type (2020-2025)

4.2.2 Global Lanreotide Injection Revenue by Type (2026-2031)

4.2.3 Global Lanreotide Injection Revenue Market Share by Type (2020-2031)

4.3 Global Lanreotide Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Lanreotide Injection Sales by Application (2020-2031)

5.1.1 Global Lanreotide Injection Sales by Application (2020-2025)

5.1.2 Global Lanreotide Injection Sales by Application (2026-2031)

5.1.3 Global Lanreotide Injection Sales Market Share by Application (2020-2031)

5.2 Global Lanreotide Injection Revenue by Application (2020-2031)

5.2.1 Global Lanreotide Injection Revenue by Application (2020-2025)

5.2.2 Global Lanreotide Injection Revenue by Application (2026-2031)

5.2.3 Global Lanreotide Injection Revenue Market Share by Application (2020-2031)

5.3 Global Lanreotide Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Ipsen

6.1.1 Ipsen Company Information

6.1.2 Ipsen Description and Business Overview

6.1.3 Ipsen Lanreotide Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ipsen Lanreotide Injection Product Portfolio

6.1.5 Ipsen Recent Developments/Updates

6.2 Cipla

6.2.1 Cipla Company Information

6.2.2 Cipla Description and Business Overview

6.2.3 Cipla Lanreotide Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Cipla Lanreotide Injection Product Portfolio

6.2.5 Cipla Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Lanreotide Injection Industry Chain Analysis

7.2 Lanreotide Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Lanreotide Injection Production Mode & Process Analysis

7.4 Lanreotide Injection Sales and Marketing

7.4.1 Lanreotide Injection Sales Channels

7.4.2 Lanreotide Injection Distributors

7.5 Lanreotide Injection Customer Analysis

8 Lanreotide Injection Market Dynamics

8.1 Lanreotide Injection Industry Trends

8.2 Lanreotide Injection Market Drivers

8.3 Lanreotide Injection Market Challenges

8.4 Lanreotide Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Ipsen S A

Cipla Ltd

List of Tables

Table 1. Global Lanreotide Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Lanreotide Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Lanreotide Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Lanreotide Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Lanreotide Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Lanreotide Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Lanreotide Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Lanreotide Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Lanreotide Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Lanreotide Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Lanreotide Injection, Product Type & Application

Table 12. Global Key Manufacturers of Lanreotide Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Lanreotide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lanreotide Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Lanreotide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Lanreotide Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Lanreotide Injection Sales Market Share by Region (2020-2025)

Table 19. Global Lanreotide Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Lanreotide Injection Sales Market Share by Region (2026-2031)

Table 21. Global Lanreotide Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Lanreotide Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Lanreotide Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Lanreotide Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Lanreotide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Lanreotide Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Lanreotide Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Lanreotide Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Lanreotide Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Lanreotide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Lanreotide Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Lanreotide Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Lanreotide Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Lanreotide Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Lanreotide Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Lanreotide Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Lanreotide Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Lanreotide Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Lanreotide Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Lanreotide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Lanreotide Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Lanreotide Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Lanreotide Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Lanreotide Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Lanreotide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Lanreotide Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Lanreotide Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Lanreotide Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Lanreotide Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Lanreotide Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Lanreotide Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Lanreotide Injection Sales Market Share by Type (2020-2025)

Table 53. Global Lanreotide Injection Sales Market Share by Type (2026-2031)

Table 54. Global Lanreotide Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Lanreotide Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Lanreotide Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Lanreotide Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Lanreotide Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Lanreotide Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Lanreotide Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Lanreotide Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Lanreotide Injection Sales Market Share by Application (2020-2025)

Table 63. Global Lanreotide Injection Sales Market Share by Application (2026-2031)

Table 64. Global Lanreotide Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Lanreotide Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Lanreotide Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Lanreotide Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Lanreotide Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Lanreotide Injection Price (US$/Unit) by Application (2026-2031)

Table 70. Ipsen Company Information

Table 71. Ipsen Description and Business Overview

Table 72. Ipsen Lanreotide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Ipsen Lanreotide Injection Product

Table 74. Ipsen Recent Developments/Updates

Table 75. Cipla Company Information

Table 76. Cipla Description and Business Overview

Table 77. Cipla Lanreotide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Cipla Lanreotide Injection Product

Table 79. Cipla Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. Lanreotide Injection Distributors List

Table 83. Lanreotide Injection Customers List

Table 84. Lanreotide Injection Market Trends

Table 85. Lanreotide Injection Market Drivers

Table 86. Lanreotide Injection Market Challenges

Table 87. Lanreotide Injection Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of Lanreotide Injection

Figure 2. Global Lanreotide Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lanreotide Injection Market Share by Type: 2024 & 2031

Figure 4. Sustained Release Formulation Product Picture

Figure 5. Long-acting Formula Product Picture

Figure 6. Global Lanreotide Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Lanreotide Injection Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Lanreotide Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Lanreotide Injection Market Size (2020-2031) & (US$ Million)

Figure 13. Global Lanreotide Injection Sales (2020-2031) & (K Units)

Figure 14. Global Lanreotide Injection Average Price (US$/Unit) & (2020-2031)

Figure 15. Lanreotide Injection Report Years Considered

Figure 16. Lanreotide Injection Sales Share by Manufacturers in 2024

Figure 17. Global Lanreotide Injection Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Lanreotide Injection Players: Market Share by Revenue in Lanreotide Injection in 2024

Figure 19. Lanreotide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Lanreotide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Lanreotide Injection Sales Market Share by Country (2020-2031)

Figure 22. North America Lanreotide Injection Revenue Market Share by Country (2020-2031)

Figure 23. United States Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Lanreotide Injection Sales Market Share by Country (2020-2031)

Figure 26. Europe Lanreotide Injection Revenue Market Share by Country (2020-2031)

Figure 27. Germany Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Lanreotide Injection Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Lanreotide Injection Revenue Market Share by Region (2020-2031)

Figure 34. China Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Lanreotide Injection Sales Market Share by Country (2020-2031)

Figure 42. Latin America Lanreotide Injection Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Lanreotide Injection Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Lanreotide Injection Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Lanreotide Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Lanreotide Injection by Type (2020-2031)

Figure 53. Global Revenue Market Share of Lanreotide Injection by Type (2020-2031)

Figure 54. Global Lanreotide Injection Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Lanreotide Injection by Application (2020-2031)

Figure 56. Global Revenue Market Share of Lanreotide Injection by Application (2020-2031)

Figure 57. Global Lanreotide Injection Price (US$/Unit) by Application (2020-2031)

Figure 58. Lanreotide Injection Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lanreotide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Somatuline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Somatuline Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Octreotide Drugs Market Research Report 2024

Sandostatin LAR Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Somatostatin Analogue Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sandostatin LAR Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Somatostatin Analogues LA SSAs Market Research Report 2024

Global Octreotide Acetate Microspheres for Injection Market Research Report 2024

Global Somatostatin for Injection Market Research Report 2024

Global Octreotide Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Manmade Version of Somatostatin Market Research Report 2024

Somatostatin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insulin Glargine Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Somatostatin and Somatostatin Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Somatostatin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Growth Hormone inhibiting Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acromegaly Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted SSTR Radionuclide Drug Conjugates Market Research Report 2024

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions